BioNTech, CureVac claim bulk of Germany’s €750m COVID-19 vaccines fundIn May, Germany pledged to provide up to €750 million ($889 million) in funding to support vaccines against Share XBioNTech, CureVac claim bulk of Germany’s €750m COVID-19 vaccines fundhttps://pharmaphorum.com/news/biontech-curevac-claim-bulk-of-germanys-e750m-covid-19-vaccines-fund/
UK announces COVID-19 vaccine deals with BioNTech/Pfizer and ValnevaThe UK has secured 90 million doses of two different COVID-19 vaccines from BioNTech/Pfizer and Valneva, with an option of 40 million doses Share XUK announces COVID-19 vaccine deals with BioNTech/Pfizer and Valnevahttps://pharmaphorum.com/news/uk-announces-covid-19-vaccine-deals-with-biontechl-pfizer-and-valneva/
CureVac claims €75m in EU funding for mRNA COVID-19 vaccineGerman vaccine firm CureVac has been awarded a €75 million loan from the European Investment Bank to boost Share XCureVac claims €75m in EU funding for mRNA COVID-19 vaccinehttps://pharmaphorum.com/news/curevac-claims-e75m-in-eu-funding-for-mrna-covid-19-vaccine/
Trump tried to secure CureVac coronavirus vaccine for US only – reportsThe ugly side of the coronavirus outbreak continues to dominate the news, amid reports that the Trump administration Share XTrump tried to secure CureVac coronavirus vaccine for US only – reportshttps://pharmaphorum.com/news/trump-tried-to-secure-coronavirus-vaccine-for-us-only-reports/
Lilly joins cancer vaccine race with CureVac allianceLilly has signed a deal with CureVac to develop up to five next-generation cancer vaccines which use messenger Share XLilly joins cancer vaccine race with CureVac alliancehttps://pharmaphorum.com/news/lilly-joins-cancer-vaccine-race-curevac-alliance/
